Physician profile

Reed A Shank

Urology · Cincinnati, OH

NPI 1922042498

$1,161.99

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Janssen Biotech, INC. $181.44 2019-2020
Boston Scientific Corporation $158.15 2019
Coloplast Corp $148.62 2019-2020
Astrazeneca Pharmaceuticals LP $125.48 2021
Neotract INC. $124.03 2019-2020
Procept Biorobotics Corporation $100.65 2019-2020
Astellas Pharma US INC $73.24 2019-2020
Sagent Pharmaceuticals $70.15 2019
C. R. Bard, INC. & Subsidiaries $31.55 2019
Blue Earth Diagnostics $27.17 2019
Abbvie INC. $20.82 2019
Dendreon Pharmaceuticals LLC $19.67 2019
Genzyme Corporation $18.08 2019
Rochester Medical Corporation $17.94 2019
Endo Pharmaceuticals INC. $16.56 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Tolmar Pharmaceuticals, INC. $15.89 2019
Ferring Pharmaceuticals INC. $12.55 2019

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Reed A Shank

$1,161.99

in general payments reported 2019-2025

Years
2019-2021
Top company
Janssen Biotech, INC.

https://glasscript.com/doctor/1072804/reed-a-shank

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.